Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial
Alfonso Gómez‐Iturriaga(BioCruces Health research Institute), Juanita Crook, José I. López(BioCruces Health research Institute), José María Lamo-Espinosa, Ana Ezquerro(Hospital de Cruces), Ana Irasarri(BioCruces Health research Institute), Pablo Mínguez(Hospital de Cruces), Pedro Bilbao(BioCruces Health research Institute), F. Casquero, A. Urresola(Hospital de Cruces), Roberto Llarena(Hospital de Cruces)
Cited by 79
Related Papers
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
|Cell|2018|565
Actomyosin-Mediated Cellular Tension Drives Increased Tissue Stiffness and β-Catenin Activation to Induce Epidermal Hyperplasia and Tumor Growth
|Cancer Cell|2011|544
<i>In situ</i>force mapping of mammary gland transformation
|Integrative Biology|2011|288